Y. Yamaguchi et al., EFFECTS OF ORAL AND INTRAVENTRICULAR ADMINISTRATION OF GINSENOSIDE RG1 ON THE PERFORMANCE IMPAIRED BY SCOPOLAMINE IN RATS, Biomedical research, 17(6), 1996, pp. 487-490
A single oral administration of ginsenoside Rg1 (1 and 2 mg/rat) did n
ot have ameliorating effects on impaired performance caused in rats by
scopolamine in a radial-arm maze. However, the oral administration of
the same doses of Rg1, which was packed in an enteric capsule, improv
ed the impaird performance. These results suggest that Rg1 not in the
capsule was decomposed by gastric juices in the stomach and that Rg1 i
n the enteric capsule was not damaged by gastric juices and reached th
e intestine to be absorbed. A single intracerebroventricular injection
with Rg1 at doses of 0.1 and 0.5 mu g/rat, which were ineffective whe
n given intraperitoneally (9), had ameliorating effects on the impaire
d performance. It seems that the brain is a target of Rg1 given system
ically. The mitigating action of Rg1 is discussed in relation to the c
entral cholinergic system.